The Tumor Microenvironment of Clear-Cell Ovarian Cancer
Michael-John Devlin, Frances R. Balkwill(Queen Mary University of London), Panoraia Kotantaki(Queen Mary University of London), Rowan Miller(Queen Mary University of London), Florian Laforêts(Queen Mary University of London), Dale W. Garsed(Peter MacCallum Cancer Centre), Jacqueline McDermott(Imperial College London), Eleni Maniati(Queen Mary University of London), Rebecca Kristeleit(Guy's and St Thomas' NHS Foundation Trust), David D.L. Bowtell(The University of Melbourne)
Cited by 41
Related Papers
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
“Re-educating” tumor-associated macrophages by targeting NF-κB
|The Journal of Experimental Medicine|2008|780
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
|Journal of Clinical Investigation|2012|591